Dr Agarwals Eye Hospital share price today

Dr Agarwals Eye Hospital Ltd's share price was ₹5,380.00 at the close on 6 November 2026. It has been rising for 24 weeks. That is 6.0% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 14 weeks in a row.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Dr Agarwals Eye Hospital Ltd is in stage 2. The phase helps read everything below.

In the last 52 weeks it traded between ₹4,475 and ₹5,735, and at that close it sat 72% of the way up from that low.

Over the last 11 years the share price moved +2,777% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: revenue up on a year earlier for 11 quarters in a row (every quarter we can compare), highest quarterly profit in 15 quarters and highest quarterly revenue in 15 quarters.

1. Revenue up on a year earlier for 11 quarters in a row (every quarter we can compare)

   In the June 2026 quarter revenue was ₹143 crore, +22.2% on a year earlier.

2. Highest quarterly profit in 15 quarters

   Profit of ₹23 crore in the June 2026 quarter is the highest of the last 15 quarters.

3. Highest quarterly revenue in 15 quarters

   Revenue of ₹143 crore in the June 2026 quarter is the highest of the last 15 quarters.

For April to June 2026 (the quarter ended 30 June 2026), Dr Agarwals Eye Hospital reported revenue of ₹143 crore, up 22.2% from ₹117 crore a year earlier, and a profit of ₹23.0 crore, up 35.3% from ₹17.0 crore.

Dr Agarwals Eye Hospital results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Dr Agarwals Eye Hospital closed at ₹5,380.00 on 6 November 2026, up 3.2% from ₹5,213.15 a year earlier (7 November 2025) and up 827.2% over five years. Its highest weekly close since March 2016 was ₹6,936.15 on 17 January 2025.

Dr Agarwals Eye Hospital share price: then and now

Weekly closing prices. Each change is the move from that price to the 6 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

558 weekly closes from 10 March 2016 to 6 November 2026.

6 Nov 2026: Dr Agarwals Eye Hospital closed at ₹5,380.00, up 1.9% on the week and up 4.6% on the month. 2 Sep 2026: ex-date for a dividend of ₹4 a share.

Earlier

• Results for April to June 2026: Revenue up 22.2% and profit up 35.3% on a year earlier.

Dr Agarwals Eye Hospital paid ₹4 a share in regular dividends in the 12 months to 7 November 2026 (1 payment), a yield of 0.07% at the ₹5,380.00 close on 6 November 2026. The last was a dividend of ₹4 a share, ex-date 2 September 2026.

Dr Agarwals Eye Hospital dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Dr Agarwals Eye Hospital Ltd paid out 5% of its profit as dividends in FY26, and it paid a dividend in 11 of its last 13 reported years.

From the NSE corporate-actions record, read 7 November 2026.

Dr Agarwals Eye Hospital is on one of our India lists: Momentum stocks.

Dr Agarwals Eye Hospital Ltd earned ₹23.0 Cr of net profit in the Jun 2026 quarter, +35.3% on the same quarter a year earlier. Full-year FY26 profit was ₹70.0 Cr. That is 16.1% of the quarter's revenue. The same quarter a year earlier earned ₹17.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹70.0 Cr (+27.3% on the year before).

Why profit moved: revenue changed +22.2% on a year earlier and the margin moved −2.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed +35.3% and revenue +20.0%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

Dr Agarwals Eye Hospital Ltd reported ₹143 Cr of revenue in the Jun 2026 quarter, +22.2% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 10 years it has grown 13.1% a year on average. The last full year, FY26, came in at ₹471 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹497 Cr.

FY26 revenue was ₹471 Cr, +18.6% on the year before.

Recent pace: the last four quarters grew +20.0% on average, against 13.1% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +20.0%, against +20.7% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +31.6%, against +23.7% a year (accelerating).

Dr Agarwals Eye Hospital Ltd's operating margin was 30.0% in the Jun 2026 quarter, 2.0 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 13 years it has been between 9.0% and 31.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −1.5 percentage points on the year while gross margin changed +1.0 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold.

Over the last 3 years, 192% of Dr Agarwals Eye Hospital Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹145 Cr of operating cash against ₹70.0 Cr of profit. After ₹125 Cr of spending on assets, ₹20.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 192% of profit came in as cash: the cash cycle got 229 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 3.5× depreciation over three years. The next section checks what that spending is building.

Dr Agarwals Eye Hospital Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −31 days in FY26, up from −260 days in FY21. It spent ₹390 Cr on assets over the last 3 years. Customers take 14 days to pay, and stock sits for 51 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹471 Cr, each day of that cycle ties up about ₹1.3 Cr, so roughly −₹40.0 Cr is tied up in the business at any time.

FY26: customers took 14 days to pay and stock sat for 51 days, about 1.7 months of sales sitting as stock, for a full cycle of −31 days, longer than FY21's −260.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 51 days. Customers pay about 14 days after that. Suppliers are paid at 97 days. Together that makes the −31-day cycle.

Spending on assets: ₹390 Cr over the last 3 years, against ₹112 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹197 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Dr Agarwals Eye Hospital Ltd's P/E is 34.2×, in the middle of its own history: higher than 66% of past readings. Its usual P/E (the middle reading) is 29.6×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.